Steady-state pharmacokinetics of midazolam maleate

F. H. Sarnquist; W. D. Mathers; T. F. Blaschke

doi:10.1097/00000542-197909001-00041

Steady-state pharmacokinetics of midazolam maleate

F. H. Sarnquist, W. D. Mathers, T. F. Blaschke

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Midazolam maleate does have a short (two-hour) half-life verified by this steady state study in volunteers. This short duration of action, coupled with its pharmacologic profile and water solubility make midazolam maleate a promising agent for anesthesia use.

Original language	English (US)
Pages (from-to)	S41
Journal	Anesthesiology
Volume	51
Issue number	3 SUPPL
DOIs	https://doi.org/10.1097/00000542-197909001-00041
State	Published - 1979
Externally published	Yes

ASJC Scopus subject areas

Anesthesiology and Pain Medicine

Access to Document

10.1097/00000542-197909001-00041

Cite this

@article{2739553f59fc4ae8b27a978f572a47da,

title = "Steady-state pharmacokinetics of midazolam maleate",

abstract = "Midazolam maleate does have a short (two-hour) half-life verified by this steady state study in volunteers. This short duration of action, coupled with its pharmacologic profile and water solubility make midazolam maleate a promising agent for anesthesia use.",

author = "Sarnquist, {F. H.} and Mathers, {W. D.} and Blaschke, {T. F.}",

year = "1979",

doi = "10.1097/00000542-197909001-00041",

language = "English (US)",

volume = "51",

pages = "S41",

journal = "Anesthesiology",

issn = "0003-3022",

publisher = "Lippincott Williams and Wilkins",

number = "3 SUPPL",

}

TY - JOUR

T1 - Steady-state pharmacokinetics of midazolam maleate

AU - Sarnquist, F. H.

AU - Mathers, W. D.

AU - Blaschke, T. F.

PY - 1979

Y1 - 1979

N2 - Midazolam maleate does have a short (two-hour) half-life verified by this steady state study in volunteers. This short duration of action, coupled with its pharmacologic profile and water solubility make midazolam maleate a promising agent for anesthesia use.

AB - Midazolam maleate does have a short (two-hour) half-life verified by this steady state study in volunteers. This short duration of action, coupled with its pharmacologic profile and water solubility make midazolam maleate a promising agent for anesthesia use.

UR - http://www.scopus.com/inward/record.url?scp=0018664699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018664699&partnerID=8YFLogxK

U2 - 10.1097/00000542-197909001-00041

DO - 10.1097/00000542-197909001-00041

M3 - Article

AN - SCOPUS:0018664699

SN - 0003-3022

VL - 51

SP - S41

JO - Anesthesiology

JF - Anesthesiology

IS - 3 SUPPL

ER -

Steady-state pharmacokinetics of midazolam maleate

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this